Stock Price Quote

JB CHEMICALS & PHARMACEUTICALS LTD.

NSE : JBCHEPHARMBSE : 506943ISIN CODE : INE572A01036Industry : Pharmaceuticals & DrugsHouse : Private
BSE1810.0020.2 (+1.13 %)
PREV CLOSE ( ) 1789.80
OPEN PRICE ( ) 1791.90
BID PRICE (QTY) 1809.65 (14)
OFFER PRICE (QTY) 1811.00 (3)
VOLUME 1549
TODAY'S LOW / HIGH ( )1791.80 1818.55
52 WK LOW / HIGH ( )1185 1935
NSE1810.3019.8 (+1.11 %)
PREV CLOSE( ) 1790.50
OPEN PRICE ( ) 1790.50
BID PRICE (QTY) 1810.25 (3)
OFFER PRICE (QTY) 1810.30 (8)
VOLUME 41827
TODAY'S LOW / HIGH( ) 1785.05 1819.50
52 WK LOW / HIGH ( )1183.8 1940
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 18-12 1976
Management Info
Arun Duggal - Chairman - Managing Director
Registered Office

Address Neelam Centre, ' B 'wing,4th Floor ,Hind Cycle Road, Worli,
Mumbai,
Maharashtra-400030

Phone 022- 2482 2222

Email secretarialijftjbpharma.com

Website www.jbpharma.com

Registrars Details
Datamatics Business Solutions Ltd.
Plot No. A 16 & 17,Part B Cross Lane,MIDC, Andheri (E),Mumbai
Listing : BSE, NSE, MCX

NEWS

03Jul J. B. Chemicals & Pharmaceuticals info
J. B. Chemicals & Pharmaceuticals has informed that it enclosed news..
06Jun Announcement under Regulation 30 (LOD
Allotment of equity shares on exercise of stock options pursuant to Empl..
24May J.B. Chemicals & Pharmaceuticals infor
Pursuant to Regulation 30 read with Schedule III and Regulation 46(2)(oa..
20Dec JB Chemicals & Pharmaceuticals trades
JB Chemicals & Pharmaceuticals is currently trading at Rs. 1472.90,..
19Dec JB Chemicals & Pharmaceuticals to exec
JB Chemicals & Pharmaceuticals has received approval for execution o..

Financials

in Millions
QTR Mar 24 ANNUAL 24
Net Profit1258.55433.6
Gross Profit 1631.1 7383.4
Operating Profit 2111.59141
Net Sales 809232986.4

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  27917.50 (1.86%)
M.Cap ( in Cr)59219.15
Dr. Reddy's Lab (BSE)
peergroup  6762.65 (1.86%)
M.Cap ( in Cr)112776.88
Orchid Pharma (BSE)
peergroup  1377.10 (6.05%)
M.Cap ( in Cr)7097.89
Neuland Laboratories (BSE)
peergroup  8201.65 (0.95%)
M.Cap ( in Cr)10609.61
Torrent Pharma (BSE)
peergroup  3023.55 (2.55%)
M.Cap ( in Cr)101922.84

Shareholding Pattern

PROMOTERS 53.77%
NON-INSTITUTION 16.43%
MUTUAL FUNDS/UTI 15.04%
FI/BANKS/INSURANCE 1.93%
GOVERNMENT 0%
FII 0%

About JB Chemicals & Pharmaceuticals Ltd.

JB Chemicals & Pharmaceuticals Ltd. was incorporated in the year 1976. Its today's share price is 1810. Its current market capitalisation stands at Rs 28144.78 Cr. In the latest quarter, company has reported Gross Sales of Rs. 29916.14 Cr and Total Income of Rs.28928.11 Cr. The company's management includes Arun Duggal, Akshay Tanna, Prashant Kumar, Gaurav Trehan, Sumit Bose, Padmini Khare Kaicker, Nikhil Chopra, Sandeep Phadnis.

It is listed on the BSE with a BSE Code of 506943 , NSE with an NSE Symbol of JBCHEPHARM and ISIN of INE572A01036. It's Registered office is at Neelam Centre, ' B 'wing,4th Floor ,Hind Cycle Road, WorliMumbai-400030, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Damania & Varaiya, Deloitte Haskins & Sells LLP, DNV & Co, JK Shah & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.